Identification and management of neonatal hypoglycaemia in the full-term infant (British Association of Perinatal Medicine—Framework for Practice)

Levene, Ilana; Wilkinson, Dominic

doi:10.1136/archdischild-2017-314050

Cited by 22 publications

(11 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SGA babies have a range of disadvantages and risks related to in utero events and some may be more physiologically disadvantaged at birth than others. The British Association of Perinatal Medicine Guidelines (Levene & Wilkinson 2017) identify babies born below the 2 nd population based centile as amongst those at risk of hypoglycaemia in the postnatal period. .…”

Section: Introductionmentioning

confidence: 99%

The establishment of breastfeeding in the small-for-gestational-age baby

Dooks

Owens

Stacey

2020

British Journal of Midwifery

View full text Add to dashboard Cite

Background Term babies born smaller than expected for a given gestation are at greater risk of short- and long-term health conditions. Breastmilk is the optimum nutrition for all babies and offers specific protection from the risks that follow from being born small for gestational age. Aim To explore breastfeeding outcomes for babies born with a birthweight below the 10th centile. Methods Data were collected on all women giving birth in one maternity unit in the north of England over a year. Method of feeding at three time points was compared between small-for-gestational-age and appropriately grown babies. Findings Small-for-gestational-age babies were significantly less likely to be breastfeeding at discharge from hospital and community services compared to larger babies. Conclusion This study suggests that small-for-gestational-age babies are disadvantaged in establishing breastfeeding.

show abstract

Section: Introductionmentioning

confidence: 99%

The establishment of breastfeeding in the small-for-gestational-age baby

Dooks

Owens

Stacey

2020

British Journal of Midwifery

View full text Add to dashboard Cite

show abstract

“…Neonatal hypoglycaemia will be diagnosed based on the Paediatric Endocrine Society and British Association of Perinatal Medicine. 18 If the blood glucose is less than 45 mg/dL (2.5 mmol/L), glucogel with a milk feed is to be given up to three times. If blood glucose remains at 25 mg/dL (1.4 mmol/L) up to two times, then the neonate will be admitted to the Neonatal Intensive Care Unit (NICU) for intravenous dextrose.…”

Section: Methodsmentioning

confidence: 99%

Effect of antenatal dietary myo-inositol supplementation on the incidence of gestational diabetes mellitus and fetal outcome: protocol for a double-blind randomised controlled trial

et al. 2022

View full text Add to dashboard Cite

IntroductionGestational diabetes mellitus (GDM) affects 23.6% of Qatari women and is associated with maternal and perinatal morbidity and long-term risk of developing type 2 diabetes. A number of challenges exist with current interventions, including non-compliance with dietary advice, the reluctance of mothers to ingest metformin tablets or use insulin injections. These challenges highlight the importance of pursuing evidence-based prevention strategies. Myo-inositol is readily available as an US Food and Drug Administration-approved food supplement with emerging but limited evidence suggesting it may be beneficial in reducing the incidence of GDM. Further studies, such as this one, from different ethnic contexts and with differing risk factors, are urgently needed to assess myo-inositol effects on maternal and neonatal outcomes.Methods and analysisThis study is a prospective, randomised, double-blinded, placebo controlled clinical trial to either myo-inositol supplementation or placebo.We plan to enrol 640 pregnant women attending antenatal care at Sidra Medicine, Doha, Qatar, 320 in each arm. All participants will complete at least 12 weeks of supplementation prior to undertaking the Oral Glucose Tolerance Test at 24–28 weeks. The daily use of the trial supplementation will continue until the end of pregnancy. All outcome measures will be collected from the electronic medical records.Ethics and disseminationEthical approval for the study was obtained on 12 April 2021 from Sidra Medicine (IRB number 1538656). Results of the primary trial outcome and secondary endpoints will be submitted for publication in a peer-reviewed journal.Trial registration numberProspectively registered on 26 May 2021. Registration number ISRCTN16448440 (ISRCTN registry).

show abstract

“…27 Maternal and infant categories at increased risk for hypoglycemia are listed in Table 2. [47][48][49] Large for gestational age infants born to screened nondiabetic mothers appear not at risk of hypoglycemia 50 nor at increased risk of poor psychomotor development at 4 years of age. 51 Umbilical cord blood glucose does not seem to predict early hypoglycemia.…”

Section: Risk Factors For Hypoglycemiamentioning

confidence: 99%

“…As the ''normal'' range of blood glucose is different for each newborn and depends upon a number of factors 13 including birth weight, gestational age, availability of energy stores, feeding status, and presence or absence of disease, any hypoglycemia management must account for the overall metabolic and physiologic status of the infant, and should not unnecessarily disrupt the mother-infant relationship and breastfeeding. Several authors have suggested algorithms for screening and treatment, 2,47,48,[77][78][79] and the United Nations Children's Fund (UNICEF UK) published a monograph on how to develop a policy on the prevention and management of newborn hypoglycemia. 80 Of the multiple guidelines, algorithms, and practice frameworks available, there are few that are as clear as those from the AAP, 2 the Canadian Paediatric Society, 47 the Swedish National Guideline, 78 and the British Association of Perinatal Medicine 79 as summarized by Dr. Jane Hawdon in 2019 81 (Fig.…”

Section: Dextrose Gel Treatmentmentioning

confidence: 99%

ABM Clinical Protocol #1: Guidelines for Glucose Monitoring and Treatment of Hypoglycemia in Term and Late Preterm Neonates, Revised 2021

Wight

Stehel²,

Noble³

et al. 2021

Breastfeeding Medicine

View full text Add to dashboard Cite

A central goal of The Academy of Breastfeeding Medicine is the development of clinical protocols for managing common medical conditions that may impact breastfeeding success. These protocols serve only as guidelines for the care of breastfeeding mothers and infants and do not delineate an exclusive course of treatment or serve as standards of medical care. Variations in treatment may be appropriate according to the needs of an individual patient. PurposeT o provide guidance in the first hours/days of life to: Differentiate transitional neonatal hypoglycemia from persistent pathologic hypoglycemia Prevent clinically significant hypoglycemia in newborn infants Appropriately monitor blood/plasma glucose levels in at-risk term and late preterm neonates Manage clinically significant hypoglycemia in newborn infants to prevent neurologic injury Maximize breast milk provision to babies Establish and preserve maternal milk supply during medically necessary supplementation for hypoglycemia or during separation of mother and baby. About the 2020 Revised ProtocolKey research articles before 2014 were retained and more recent information was added from primary studies and compilations. Specific studies were assigned a level of evidence, and Strength of Recommendation Taxonomy (SORT: A, B, C) 1 was used for recommendations. The SORT rating system addresses the three key elements (quality, quantity, and consistency) recommended by the Agency for Healthcare Research and Quality. Levels of evidence are applied after each specific recommendation in brackets, e.g., [A], [B], [C].Recommendations are updated based on the last 6 years of new information and critical older studies. This clinical protocol is intended to provide practitioners with pragmatic evidence-based guidance to keep infants safe while mini-

show abstract

Identification and management of neonatal hypoglycaemia in the full-term infant (British Association of Perinatal Medicine—Framework for Practice)

Cited by 22 publications

References 4 publications

The establishment of breastfeeding in the small-for-gestational-age baby

The establishment of breastfeeding in the small-for-gestational-age baby

Effect of antenatal dietary myo-inositol supplementation on the incidence of gestational diabetes mellitus and fetal outcome: protocol for a double-blind randomised controlled trial

ABM Clinical Protocol #1: Guidelines for Glucose Monitoring and Treatment of Hypoglycemia in Term and Late Preterm Neonates, Revised 2021

Contact Info

Product

Resources

About